Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jayaprakasam Bolleddula, Kevin DeMent, James P. Driscoll, Philip Worboys, Patrick J. Brassil & David L. Bourdet. (2014) Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. Drug Metabolism Reviews 46:3, pages 379-419.
Read now
Read now
M. Strolin Benedetti & P. Dostert. (1994) Contribution of Amine Oxidases to the Metabolism of Xenobiotics. Drug Metabolism Reviews 26:3, pages 507-535.
Read now
Read now
Articles from other publishers (45)
Olga Buneeva, Valerii Fedchenko, Arthur Kopylov & Alexei Medvedev. (2020) Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA. Biomedicines 8:12, pages 591.
Crossref
Crossref
O. A. Buneeva, M. V. Medvedeva, A. T. Kopylov & A. E. Medvedev. (2019) Ubiquitin Subproteome of Brain Mitochondria and Its Changes Induced by Experimental Parkinsonism and Action of Neuroprotectors. Biochemistry (Moscow) 84:11, pages 1359-1374.
Crossref
Crossref
Lindsey R. Drake, Allen F. Brooks, Anthony J. Mufarreh, Jonathan M. Pham, Robert A. Koeppe, Xia Shao, Peter J. H. Scott & Michael R. Kilbourn. (2018)
Deuterium Kinetic Isotope Effect Studies of a Potential
in Vivo
Metabolic Trapping Agent for Monoamine Oxidase B
. ACS Chemical Neuroscience 9:12, pages 3024-3027.
Crossref
Crossref
Olga Buneeva, Arthur Kopylov, Inga Kapitsa, Elena Ivanova, Victor Zgoda & Alexei Medvedev. (2018) The Effect of Neurotoxin MPTP and Neuroprotector Isatin on the Profile of Ubiquitinated Brain Mitochondrial Proteins. Cells 7:8, pages 91.
Crossref
Crossref
Alexei Medvedev, Olga Buneeva, Oksana Gnedenko, Pavel Ershov & Alexis Ivanov. (2018) Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications. BioFactors 44:2, pages 95-108.
Crossref
Crossref
Avinash C. Tripathi, Savita Upadhyay, Sarvesh Paliwal & Shailendra K. Saraf. (2018) Privileged scaffolds as MAO inhibitors: Retrospect and prospects. European Journal of Medicinal Chemistry 145, pages 445-497.
Crossref
Crossref
Ana López, Francisco Ortiz, Carolina Doerrier, Carmen Venegas, Marisol Fernández-Ortiz, Paula Aranda, María E. Díaz-Casado, Beatriz Fernández-Gil, Eliana Barriocanal-Casado, Germaine Escames, Luis C. López & Darío Acuña-Castroviejo. (2017) Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases. PLOS ONE 12:8, pages e0183090.
Crossref
Crossref
A. E. Medvedev, O. A. Buneeva, A. T. Kopylov, O. V. Tikhonova, M. V. Medvedeva, L. N. Nerobkova, I. G. Kapitsa & V. G. Zgoda. (2017) Brain mitochondrial subproteome of Rpn10-binding proteins and its changes induced by the neurotoxin MPTP and the neuroprotector isatin. Biochemistry (Moscow) 82:3, pages 330-339.
Crossref
Crossref
R. S. Foti & D. K. Dalvie. (2016) Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics. Drug Metabolism and Disposition 44:8, pages 1229-1245.
Crossref
Crossref
Alexander V. LyubimovMatthew J. Hutzler & Matthew A. Cerny. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
40
.
Donald J. AbrahamBrian S. J. Blagg & M. Kyle Hadden. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
382
456
.
Donald J. AbrahamJulian Blagg. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
301
334
.
John A. Timbrell. 2008. Principles of Biochemical Toxicology. Principles of Biochemical Toxicology
139
202
.
Bernard Testa & Stefanie D. Krämer. (2008) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 5:11, pages 2171-2336.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2007) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 4:3, pages 257-405.
Crossref
Crossref
Chungang Gu, Roxane Collins, Daniel D. Holsworth, Gregory S. Walker & Richard L. Voorman. (2006)
Metabolic Aromatization of
N
-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish Peroxidase
. Drug Metabolism and Disposition 34:12, pages 2044-2055.
Crossref
Crossref
Paola Costa-Mallen, Samir N. Kelada, Lucio G. Costa & Harvey Checkoway. (2005) Characterization of the in vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene. Neuroscience Letters 383:1-2, pages 171-175.
Crossref
Crossref
. 2005. Drug Metabolism. Drug Metabolism
171
208
.
Deepak K. Dalvie & Thomas N. O'Connell. (2004) CHARACTERIZATION OF NOVEL DIHYDROTHIENOPYRIDINIUM AND THIENOPYRIDINIUM METABOLITES OF TICLOPIDINE IN VITRO: ROLE OF PEROXIDASES, CYTOCHROMES P450, AND MONOAMINE OXIDASES. Drug Metabolism and Disposition 32:1, pages 49-57.
Crossref
Crossref
Paola Costa-Mallen, Zahra Afsharinejad, Samir N. Kelada, Lucio G. Costa, Gary M. Franklin, Phillip D. Swanson, W.T. LongstrethJr.Jr., Hannah-Malia A. Viernes, Federico M. Farin, Terri Smith-Weller & Harvey Checkoway. (2004) DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls. Movement Disorders 19:1, pages 76-83.
Crossref
Crossref
M. A. HernánH. CheckowayR. O’BrienP. Costa–MallenI. De VivoG. A. ColditzD. J. HunterK. T. KelseyA. Ascherio. (2002) MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 58:9, pages 1381-1387.
Crossref
Crossref
M Kosel, C Gnerre, P Voirol, M Amey, B Rochat, C Bouras, B Testa & P Baumann. (2002) In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations. Molecular Psychiatry 7:2, pages 181-188.
Crossref
Crossref
Amit S. Kalgutkar, Deepak K. Dalvie, Neal Castagnoli, & Timothy J. Taylor. (2001) Interactions of Nitrogen-Containing Xenobiotics with Monoamine Oxidase (MAO) Isozymes A and B: SAR Studies on MAO Substrates and Inhibitors. Chemical Research in Toxicology 14:9, pages 1139-1162.
Crossref
Crossref
Philippe Lagrange, Ramon Dos Santos El-Bachá, Patrick Netter & Alain Minn. (2001) Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress. Neurotoxicity Research 3:4, pages 359-368.
Crossref
Crossref
Peter Pagel, Rainer Schubert & Hans Uwe Wolf. (2000) Development of a method for sample preparation for subsequent identification and measurement of 1,2,3,4-tetrahydroisoquinolines and other potentially neurotoxic compounds by high-performance liquid chromatography with ultraviolet and fluorescence detection in blood plasma of Parkinson?s disease patients. Journal of Chromatography B: Biomedical Sciences and Applications 746:2, pages 283-295.
Crossref
Crossref
Sandeep K. Nimkar, Stéphane Mabic, Andrea H. Anderson, Sonya L. Palmer, Thomas H. Graham, Milly de Jonge, Lisa Hazelwood, Sean J. Hislop & Neal Castagnoli. (1999) Studies on the Monoamine Oxidase-B-Catalyzed Biotransformation of 4-Azaaryl-1-methyl-1,2,3,6-tetrahydropyridine Derivatives. Journal of Medicinal Chemistry 42:10, pages 1828-1835.
Crossref
Crossref
You-Xiong Wang, Stéphane Mabic & Neal Castagnoli Jr. (1998) 1-Methyl-3-pyrrolines and 2-methylisoindolines: new classes of cyclic tertiary amine monoamine oxidase B substrates. Bioorganic & Medicinal Chemistry 6:2, pages 143-149.
Crossref
Crossref
M. Strolin Benedetti & K. F. Tipton. 1998. MAO — The Mother of all Amine Oxidases. MAO — The Mother of all Amine Oxidases
149
171
.
Sonya L. Palmer, Stéphane Mabic & Neal Castagnoli. (1997) Probing the Active Sites of Monoamine Oxidase A and B with 1,4-Disubstituted Tetrahydropyridine Substrates and Inactivators. Journal of Medicinal Chemistry 40:13, pages 1982-1989.
Crossref
Crossref
Shizuo Narimatsu, Masaya Tachibana, Yasuhiro Masubuchi & Tokuji Suzuki. (1996)
Cytochrome P4502D and -2C Enzymes Catalyze the Oxidative
N
-Demethylation of the Parkinsonism-Inducing Substance 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in Rat Liver Microsomes
. Chemical Research in Toxicology 9:1, pages 93-98.
Crossref
Crossref
Stéphane Mabic & Neal Castagnoli. (1996) Assessment of Structural Requirements for the Monoamine Oxidase-B-Catalyzed Oxidation of 1,4-Disubstituted-1,2,3,6-tetrahydropyridine Derivatives Related to the Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Medicinal Chemistry 39:19, pages 3694-3700.
Crossref
Crossref
G. Gordon Gibson & Paul SkettG. Gordon Gibson & Paul Skett. 1996. Introduction to Drug Metabolism. Introduction to Drug Metabolism
157
179
.
C.C. Finch, S.L. Ho, A.C. Williams & E.E. Billett. 1995. Current Neurochemical and Pharmacological Aspects of Biogenic Amines - Their Function, Oxidative Deamination and Inhibition. Current Neurochemical and Pharmacological Aspects of Biogenic Amines - Their Function, Oxidative Deamination and Inhibition
85
90
.
B.Kevin Park, Munir Pirmohamed & Neil R. Kitteringham. (1995) The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity. Pharmacology & Therapeutics 68:3, pages 385-424.
Crossref
Crossref
Y. Tasaki, Y. Kotake, Y. Makino, S. Ohta & M. Hirobe. 1995. Alzheimer’s and Parkinson’s Diseases. Alzheimer’s and Parkinson’s Diseases
599
604
.
H.V. Sheevers, K. Brendel, S.H. Wright, R.B. Nagle & A.J. Gandolfi. (1994) Nephrotoxicity and uptake of 1-benzyl quinolinium in precision-cut rabbit renal cortical slices. Toxicology in Vitro 8:6, pages 1243-1251.
Crossref
Crossref
Jerald L. Hoffman. 1994.
449
477
.
George T. Barthalmus, Laura K. Hardin & David Thompson. (1993) MAO-A and -B inhibitors selectivity alter Xenopus mucus-induced behaviors of snakes. Pharmacology Biochemistry and Behavior 44:2, pages 321-327.
Crossref
Crossref
H. Checkoway, L. G. Costa, J. S. Woods, A. F. Castoldi, B. O. Lund & P. D. Swanson. (1992) Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease. Journal of Neural Transmission - Parkinson's Disease and Dementia Section 4:4, pages 283-290.
Crossref
Crossref
Kazuo Matsubara, Edward J. Neafsey & Michael A. Collins. (2006) Novel S‐Adenosylmethionine‐Dependent Indole‐N‐Methylation of β‐Carbolines in Brain Particulate Fractions. Journal of Neurochemistry 59:2, pages 511-518.
Crossref
Crossref
Jeremy Z. Fields, Rudolph R. Albores, Edward J. Neafsey & Michael A. Collins. (1992) Inhibition of mitochondrial succinate oxidation?Similarities and differences between N-methylated ?-carbolines and MPP+. Archives of Biochemistry and Biophysics 294:2, pages 539-543.
Crossref
Crossref
Ramin A. Behmand & Sami I. Harik. (2006) Nicotine Enhances 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Neurotoxicity. Journal of Neurochemistry 58:2, pages 776-779.
Crossref
Crossref
Michael A. Collins, Edward J. Neafsey, Kazuo Matsubara, Robert J. CobuzziJr.Jr. & Hans Rollema. (1992) Indole-N-methylated ?-carbolinium ions as potential brain-bioactivated neurotoxins. Brain Research 570:1-2, pages 154-160.
Crossref
Crossref
Yoshikazu Tasaki, Yukiko Makino, Shigeru Ohta & Masaaki Hirobe. (1991) 1-Methyl- 1,2,3,4-Tetrahydroisoquinoline, Decreasing in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mouse, Prevents Parkinsonism-Like Behavior Abnormalities. Journal of Neurochemistry 57:6, pages 1940-1943.
Crossref
Crossref
Cosimo Altomare, Pierre-Alain Carrupt, Nabil El Tayar, Bernard Testa & Toshiharu Nagatsu. (1991) Electronic and Conformational Effects on the Lipophilicity of Isomers and Analogs of the Neurotoxin 1-Methyl-4-phenylpyridinium (MPP+). Helvetica Chimica Acta 74:2, pages 290-296.
Crossref
Crossref